カテゴリー： 世界, 医療/バイオ, QYResearch

経口ペプチド薬の世界市場インサイト・予測（～2028年）

【英語タイトル】Global Oral Peptide Drug Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX10446）・商品コード：QY22JLX10446
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：87
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、経口ペプチド薬のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に経口ペプチド薬の世界市場のxxx％を占める「リナクロチド」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
経口ペプチド薬の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの経口ペプチド薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

経口ペプチド薬のグローバル主要企業には、Allergan、Novo Nordisk、Synergy Pharmaceuticals （Salix）、Novartis、Chiasmaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

経口ペプチド薬市場は、種類と用途によって区分されます。世界の経口ペプチド薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
リナクロチド、インスリン、プレカナチド、シクロスポリン、オクトレオチド

【用途別セグメント】
病院、小売薬局

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 経口ペプチド薬製品概要
- 種類別市場（リナクロチド、インスリン、プレカナチド、シクロスポリン、オクトレオチド）
- 用途別市場（病院、小売薬局）
- 調査の目的
・エグゼクティブサマリー
- 世界の経口ペプチド薬販売量予測2017-2028
- 世界の経口ペプチド薬売上予測2017-2028
- 経口ペプチド薬の地域別販売量
- 経口ペプチド薬の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別経口ペプチド薬販売量
- 主要メーカー別経口ペプチド薬売上
- 主要メーカー別経口ペプチド薬価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（リナクロチド、インスリン、プレカナチド、シクロスポリン、オクトレオチド）
- 経口ペプチド薬の種類別販売量
- 経口ペプチド薬の種類別売上
- 経口ペプチド薬の種類別価格
・用途別市場規模（病院、小売薬局）
- 経口ペプチド薬の用途別販売量
- 経口ペプチド薬の用途別売上
- 経口ペプチド薬の用途別価格
・北米市場
- 北米の経口ペプチド薬市場規模（種類別、用途別）
- 主要国別の経口ペプチド薬市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの経口ペプチド薬市場規模（種類別、用途別）
- 主要国別の経口ペプチド薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の経口ペプチド薬市場規模（種類別、用途別）
- 主要国別の経口ペプチド薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の経口ペプチド薬市場規模（種類別、用途別）
- 主要国別の経口ペプチド薬市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの経口ペプチド薬市場規模（種類別、用途別）
- 主要国別の経口ペプチド薬市場規模（トルコ、サウジアラビア）
・企業情報
Allergan、Novo Nordisk、Synergy Pharmaceuticals （Salix）、Novartis、Chiasma
・産業チェーン及び販売チャネル分析
- 経口ペプチド薬の産業チェーン分析
- 経口ペプチド薬の原材料
- 経口ペプチド薬の生産プロセス
- 経口ペプチド薬の販売及びマーケティング
- 経口ペプチド薬の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 経口ペプチド薬の産業動向
- 経口ペプチド薬のマーケットドライバー
- 経口ペプチド薬の課題
- 経口ペプチド薬の阻害要因
・主な調査結果

The drugs give through oral.
Market Analysis and Insights: Global Oral Peptide Drug Market
The global Oral Peptide Drug market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Linaclotide accounting for % of the Oral Peptide Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Oral Peptide Drug market size is valued at US$ million in 2021, while the North America and Europe Oral Peptide Drug are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Oral Peptide Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oral Peptide Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oral Peptide Drug market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oral Peptide Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oral Peptide Drug market.
Global Oral Peptide Drug Scope and Market Size
Oral Peptide Drug market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Oral Peptide Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Linaclotide
Insulin
Plecanatide
Cyclosporine
Octreotide
Segment by Application
Hospital
Retail Pharmacy
By Company
Allergan
Novo Nordisk
Synergy Pharmaceuticals （Salix）
Novartis
Chiasma
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Peptide Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Linaclotide
1.2.3 Insulin
1.2.4 Plecanatide
1.2.5 Cyclosporine
1.2.6 Octreotide
1.3 Market by Application
1.3.1 Global Oral Peptide Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oral Peptide Drug Market Perspective (2017-2028)
2.2 Oral Peptide Drug Growth Trends by Region
2.2.1 Oral Peptide Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Oral Peptide Drug Historic Market Size by Region (2017-2022)
2.2.3 Oral Peptide Drug Forecasted Market Size by Region (2023-2028)
2.3 Oral Peptide Drug Market Dynamics
2.3.1 Oral Peptide Drug Industry Trends
2.3.2 Oral Peptide Drug Market Drivers
2.3.3 Oral Peptide Drug Market Challenges
2.3.4 Oral Peptide Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Peptide Drug Players by Revenue
3.1.1 Global Top Oral Peptide Drug Players by Revenue (2017-2022)
3.1.2 Global Oral Peptide Drug Revenue Market Share by Players (2017-2022)
3.2 Global Oral Peptide Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oral Peptide Drug Revenue
3.4 Global Oral Peptide Drug Market Concentration Ratio
3.4.1 Global Oral Peptide Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Peptide Drug Revenue in 2021
3.5 Oral Peptide Drug Key Players Head office and Area Served
3.6 Key Players Oral Peptide Drug Product Solution and Service
3.7 Date of Enter into Oral Peptide Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Peptide Drug Breakdown Data by Type
4.1 Global Oral Peptide Drug Historic Market Size by Type (2017-2022)
4.2 Global Oral Peptide Drug Forecasted Market Size by Type (2023-2028)
5 Oral Peptide Drug Breakdown Data by Application
5.1 Global Oral Peptide Drug Historic Market Size by Application (2017-2022)
5.2 Global Oral Peptide Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Oral Peptide Drug Market Size (2017-2028)
6.2 North America Oral Peptide Drug Market Size by Type
6.2.1 North America Oral Peptide Drug Market Size by Type (2017-2022)
6.2.2 North America Oral Peptide Drug Market Size by Type (2023-2028)
6.2.3 North America Oral Peptide Drug Market Share by Type (2017-2028)
6.3 North America Oral Peptide Drug Market Size by Application
6.3.1 North America Oral Peptide Drug Market Size by Application (2017-2022)
6.3.2 North America Oral Peptide Drug Market Size by Application (2023-2028)
6.3.3 North America Oral Peptide Drug Market Share by Application (2017-2028)
6.4 North America Oral Peptide Drug Market Size by Country
6.4.1 North America Oral Peptide Drug Market Size by Country (2017-2022)
6.4.2 North America Oral Peptide Drug Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Oral Peptide Drug Market Size (2017-2028)
7.2 Europe Oral Peptide Drug Market Size by Type
7.2.1 Europe Oral Peptide Drug Market Size by Type (2017-2022)
7.2.2 Europe Oral Peptide Drug Market Size by Type (2023-2028)
7.2.3 Europe Oral Peptide Drug Market Share by Type (2017-2028)
7.3 Europe Oral Peptide Drug Market Size by Application
7.3.1 Europe Oral Peptide Drug Market Size by Application (2017-2022)
7.3.2 Europe Oral Peptide Drug Market Size by Application (2023-2028)
7.3.3 Europe Oral Peptide Drug Market Share by Application (2017-2028)
7.4 Europe Oral Peptide Drug Market Size by Country
7.4.1 Europe Oral Peptide Drug Market Size by Country (2017-2022)
7.4.2 Europe Oral Peptide Drug Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral Peptide Drug Market Size (2017-2028)
8.2 Asia-Pacific Oral Peptide Drug Market Size by Type
8.2.1 Asia-Pacific Oral Peptide Drug Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Oral Peptide Drug Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Oral Peptide Drug Market Share by Type (2017-2028)
8.3 Asia-Pacific Oral Peptide Drug Market Size by Application
8.3.1 Asia-Pacific Oral Peptide Drug Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Oral Peptide Drug Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Oral Peptide Drug Market Share by Application (2017-2028)
8.4 Asia-Pacific Oral Peptide Drug Market Size by Region
8.4.1 Asia-Pacific Oral Peptide Drug Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Oral Peptide Drug Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Oral Peptide Drug Market Size (2017-2028)
9.2 Latin America Oral Peptide Drug Market Size by Type
9.2.1 Latin America Oral Peptide Drug Market Size by Type (2017-2022)
9.2.2 Latin America Oral Peptide Drug Market Size by Type (2023-2028)
9.2.3 Latin America Oral Peptide Drug Market Share by Type (2017-2028)
9.3 Latin America Oral Peptide Drug Market Size by Application
9.3.1 Latin America Oral Peptide Drug Market Size by Application (2017-2022)
9.3.2 Latin America Oral Peptide Drug Market Size by Application (2023-2028)
9.3.3 Latin America Oral Peptide Drug Market Share by Application (2017-2028)
9.4 Latin America Oral Peptide Drug Market Size by Country
9.4.1 Latin America Oral Peptide Drug Market Size by Country (2017-2022)
9.4.2 Latin America Oral Peptide Drug Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Peptide Drug Market Size (2017-2028)
10.2 Middle East & Africa Oral Peptide Drug Market Size by Type
10.2.1 Middle East & Africa Oral Peptide Drug Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Oral Peptide Drug Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Oral Peptide Drug Market Share by Type (2017-2028)
10.3 Middle East & Africa Oral Peptide Drug Market Size by Application
10.3.1 Middle East & Africa Oral Peptide Drug Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Oral Peptide Drug Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Oral Peptide Drug Market Share by Application (2017-2028)
10.4 Middle East & Africa Oral Peptide Drug Market Size by Country
10.4.1 Middle East & Africa Oral Peptide Drug Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Oral Peptide Drug Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Oral Peptide Drug Introduction
11.1.4 Allergan Revenue in Oral Peptide Drug Business (2017-2022)
11.1.5 Allergan Recent Developments
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Details
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk Oral Peptide Drug Introduction
11.2.4 Novo Nordisk Revenue in Oral Peptide Drug Business (2017-2022)
11.2.5 Novo Nordisk Recent Developments
11.3 Synergy Pharmaceuticals （Salix）
11.3.1 Synergy Pharmaceuticals （Salix） Company Details
11.3.2 Synergy Pharmaceuticals （Salix） Business Overview
11.3.3 Synergy Pharmaceuticals （Salix） Oral Peptide Drug Introduction
11.3.4 Synergy Pharmaceuticals （Salix） Revenue in Oral Peptide Drug Business (2017-2022)
11.3.5 Synergy Pharmaceuticals （Salix） Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Oral Peptide Drug Introduction
11.4.4 Novartis Revenue in Oral Peptide Drug Business (2017-2022)
11.4.5 Novartis Recent Developments
11.5 Chiasma
11.5.1 Chiasma Company Details
11.5.2 Chiasma Business Overview
11.5.3 Chiasma Oral Peptide Drug Introduction
11.5.4 Chiasma Revenue in Oral Peptide Drug Business (2017-2022)
11.5.5 Chiasma Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Oral Peptide Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Linaclotide
Table 3. Key Players of Insulin
Table 4. Key Players of Plecanatide
Table 5. Key Players of Cyclosporine
Table 6. Key Players of Octreotide
Table 7. Global Oral Peptide Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Oral Peptide Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Oral Peptide Drug Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Oral Peptide Drug Market Share by Region (2017-2022)
Table 11. Global Oral Peptide Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Oral Peptide Drug Market Share by Region (2023-2028)
Table 13. Oral Peptide Drug Market Trends
Table 14. Oral Peptide Drug Market Drivers
Table 15. Oral Peptide Drug Market Challenges
Table 16. Oral Peptide Drug Market Restraints
Table 17. Global Oral Peptide Drug Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Oral Peptide Drug Revenue Share by Players (2017-2022)
Table 19. Global Top Oral Peptide Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Peptide Drug as of 2021)
Table 20. Ranking of Global Top Oral Peptide Drug Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Oral Peptide Drug Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Oral Peptide Drug Product Solution and Service
Table 24. Date of Enter into Oral Peptide Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oral Peptide Drug Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Oral Peptide Drug Revenue Market Share by Type (2017-2022)
Table 28. Global Oral Peptide Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Oral Peptide Drug Revenue Market Share by Type (2023-2028)
Table 30. Global Oral Peptide Drug Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Oral Peptide Drug Revenue Share by Application (2017-2022)
Table 32. Global Oral Peptide Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Oral Peptide Drug Revenue Share by Application (2023-2028)
Table 34. North America Oral Peptide Drug Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Oral Peptide Drug Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Oral Peptide Drug Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Oral Peptide Drug Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Oral Peptide Drug Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Oral Peptide Drug Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Oral Peptide Drug Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Oral Peptide Drug Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Oral Peptide Drug Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Oral Peptide Drug Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Oral Peptide Drug Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Oral Peptide Drug Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Oral Peptide Drug Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Oral Peptide Drug Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Oral Peptide Drug Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Oral Peptide Drug Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Oral Peptide Drug Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Oral Peptide Drug Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Oral Peptide Drug Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Oral Peptide Drug Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Oral Peptide Drug Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Oral Peptide Drug Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Oral Peptide Drug Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Oral Peptide Drug Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Oral Peptide Drug Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Oral Peptide Drug Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Oral Peptide Drug Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Oral Peptide Drug Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Oral Peptide Drug Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Oral Peptide Drug Market Size by Country (2023-2028) & (US$ Million)
Table 64. Allergan Company Details
Table 65. Allergan Business Overview
Table 66. Allergan Oral Peptide Drug Product
Table 67. Allergan Revenue in Oral Peptide Drug Business (2017-2022) & (US$ Million)
Table 68. Allergan Recent Developments
Table 69. Novo Nordisk Company Details
Table 70. Novo Nordisk Business Overview
Table 71. Novo Nordisk Oral Peptide Drug Product
Table 72. Novo Nordisk Revenue in Oral Peptide Drug Business (2017-2022) & (US$ Million)
Table 73. Novo Nordisk Recent Developments
Table 74. Synergy Pharmaceuticals （Salix） Company Details
Table 75. Synergy Pharmaceuticals （Salix） Business Overview
Table 76. Synergy Pharmaceuticals （Salix） Oral Peptide Drug Product
Table 77. Synergy Pharmaceuticals （Salix） Revenue in Oral Peptide Drug Business (2017-2022) & (US$ Million)
Table 78. Synergy Pharmaceuticals （Salix） Recent Developments
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Oral Peptide Drug Product
Table 82. Novartis Revenue in Oral Peptide Drug Business (2017-2022) & (US$ Million)
Table 83. Novartis Recent Developments
Table 84. Chiasma Company Details
Table 85. Chiasma Business Overview
Table 86. Chiasma Oral Peptide Drug Product
Table 87. Chiasma Revenue in Oral Peptide Drug Business (2017-2022) & (US$ Million)
Table 88. Chiasma Recent Developments
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Peptide Drug Market Share by Type: 2021 VS 2028
Figure 2. Linaclotide Features
Figure 3. Insulin Features
Figure 4. Plecanatide Features
Figure 5. Cyclosporine Features
Figure 6. Octreotide Features
Figure 7. Global Oral Peptide Drug Market Share by Application: 2021 VS 2028
Figure 8. Hospital Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Oral Peptide Drug Report Years Considered
Figure 11. Global Oral Peptide Drug Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Oral Peptide Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Oral Peptide Drug Market Share by Region: 2021 VS 2028
Figure 14. Global Oral Peptide Drug Market Share by Players in 2021
Figure 15. Global Top Oral Peptide Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Peptide Drug as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Oral Peptide Drug Revenue in 2021
Figure 17. North America Oral Peptide Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Oral Peptide Drug Market Size Market Share by Type (2017-2028)
Figure 19. North America Oral Peptide Drug Market Size Market Share by Application (2017-2028)
Figure 20. North America Oral Peptide Drug Market Size Share by Country (2017-2028)
Figure 21. United States Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Oral Peptide Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Oral Peptide Drug Market Size Market Share by Type (2017-2028)
Figure 25. Europe Oral Peptide Drug Market Size Market Share by Application (2017-2028)
Figure 26. Europe Oral Peptide Drug Market Size Share by Country (2017-2028)
Figure 27. Germany Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Oral Peptide Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Oral Peptide Drug Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Oral Peptide Drug Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Oral Peptide Drug Market Size Share by Region (2017-2028)
Figure 37. China Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Oral Peptide Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Oral Peptide Drug Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Oral Peptide Drug Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Oral Peptide Drug Market Size Share by Country (2017-2028)
Figure 47. Mexico Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Oral Peptide Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Oral Peptide Drug Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Oral Peptide Drug Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Oral Peptide Drug Market Size Share by Country (2017-2028)
Figure 53. Turkey Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Allergan Revenue Growth Rate in Oral Peptide Drug Business (2017-2022)
Figure 57. Novo Nordisk Revenue Growth Rate in Oral Peptide Drug Business (2017-2022)
Figure 58. Synergy Pharmaceuticals （Salix） Revenue Growth Rate in Oral Peptide Drug Business (2017-2022)
Figure 59. Novartis Revenue Growth Rate in Oral Peptide Drug Business (2017-2022)
Figure 60. Chiasma Revenue Growth Rate in Oral Peptide Drug Business (2017-2022)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed


★調査レポート[経口ペプチド薬の世界市場インサイト・予測（～2028年）] (コード：QY22JLX10446)販売に関する免責事項を必ずご確認ください。
★調査レポート[経口ペプチド薬の世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 経口ペプチド療法の世界市場インサイト・予測（～2028年）
  • 注射ペプチド薬の世界市場インサイト・予測（～2028年）
  • ペプチド-薬物複合体の世界市場インサイト・予測（～2028年）
  • 経口用新型コロナウイルス感染症治療剤の世界市場インサイト・予測（～2028年）
  • 経口薄膜薬物送達の世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆